Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests a telehealth community health worker coaching program for diabetes and high blood pressure

Tests remote coaching by community health workers for South Asian adults with diabetes and hypertension.

Plain-language title generated from the registry record
Registry title: Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension (Phase II)

Key facts

Where
Atlanta and New York, United StatesSee the 2 sites

Where in United States

  • Emory UniversityAtlanta, United StatesNo longer taking part
  • NYU Langone HealthNew York, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
NYU Langone Health
Trial code
NCT06542939
Record updated
1 October 2026
Original description
The purpose of this study is to test the effectiveness and implementation process of a culturally and contextually tailored telehealth-based community health worker (CHW) led coaching intervention for hypertension control among South Asian patients with co-morbid Diabetes Mellitus type II (DMII) and hypertension. The primary aims are to test the effectiveness of a CHW-led telehealth intervention compared to usual care, and using Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Consolidated Framework for Implementation Research (CFIR), examine the reach, adoption, fidelity, and maintenance of the intervention within clinical and community settings.Read full original descriptionShow less

Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension (Phase II)

The purpose of this study is to test the effectiveness and implementation process of a culturally and contextually tailored telehealth-based community health worker (CHW) led coaching intervention for hypertension control among South Asian patients with co-morbid Diabetes Mellitus type II (DMII) and hypertension. The primary aims are to test the effectiveness of a CHW-led telehealth intervention compared to usual care, and using Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Consolidated Framework for Implementation Research (CFIR), examine the reach, adoption, fidelity, and maintenance of the intervention within clinical and community settings.

Inclusion: identified as of South Asian ethnicity; at least 21 years of age; a diagnosis of diabetes; a diagnosis of hypertension; an uncontrolled BP reading (>130/80mmHg) in the last 6 months.

Exclusion: Type 1 diabetes or diabetes secondary to other conditions (e.g., steroid-induced, pancreatic insufficiency, or chemotherapy-induced); Under the age of 21; Malignancy or life-threatening illness with life expectancy of <5 years; Women who are pregnant at the time of screening; Inability to perform unsupervised physical activity; Diagnosed cognitive deficits or limited decision-making capacity.

ClinicalTrials.gov NCT06542939